Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

NCT01998347 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Esophageal Cancer

Interventions

DRUG: Paclitaxel liposome
DRUG: Cisplatin
DRUG: 5-fluorouracil

Sponsor

Shantou University Medical College